| 臺大學術典藏 |
2021-05-24T07:20:46Z |
Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; Su T.-H.; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:44Z |
Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
|
Yu M.-L.; Lee C.-M.; Chen C.-L.; Chuang W.-L.; Lu S.-N.; CHEN-HUA LIU; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Kao J.-H.; Su W.-W.; Lin C.-L.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Liu C.-J. |
| 臺大學術典藏 |
2021-05-24T07:20:36Z |
Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients
|
Wang C.-C.; CHEN-HUA LIU; Lin C.-L.; Wang P.-C.; Tseng T.-C.; Lin H.H.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:36Z |
Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B
|
Lin C.-L.; CHEN-HUA LIU; Wang C.-C.; Liang C.-C.; Su T.-H.; Liu C.-J.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:35Z |
Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping
|
CHEN-HUA LIU; Liang C.-C.; Liu C.-J.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:34Z |
Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial
|
CHEN-HUA LIU; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-05-24T07:20:33Z |
Peginterferon alfa-2a plus Weight-Based or Flat-Dose Ribavirin for Treatment-Naïve Hepatitis C Virus Genotype 2 Rapid Responders: A Randomized Trial
|
CHEN-HUA LIU; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; Su T.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L. |
| 臺大學術典藏 |
2021-05-24T07:20:26Z |
Comorbidities, concomitant medications and potential drug-drug interactions with interferon-free direct-acting antiviral agents in hepatitis C patients in Taiwan
|
CHEN-HUA LIU; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:23Z |
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study
|
CHEN-HUA LIU; Yu M.-L.; Peng C.-Y.; Hsieh T.-Y.; Huang Y.-H.; Su W.-W.; Cheng P.-N.; Lin C.-L.; Lo C.-C.; Chen C.-Y.; Chen J.-J.; Ma Q.; Brooks-Rooney C.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:21Z |
Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis
|
CHEN-HUA LIU; Shih Y.-L.; Yang S.-S.; Lin C.-L.; Fang Y.-J.; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-05-24T07:20:12Z |
Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan
|
Chen C.-Y.; Huang C.-F.; Cheng P.-N.; Tseng K.-C.; Lo C.-C.; Kuo H.-T.; Huang Y.-H.; Tai C.-M.; Peng C.-Y.; Bair M.-J.; Chen C.-H.; Yeh M.-L.; Lin C.-L.; Lin C.-Y.; Lee P.-L.; Chong L.-W.; Hung C.-H.; Huang J.-F.; Yang C.-C.; Hu J.-T.; Lin C.-W.; Chen C.-T.; Wang C.-C.; Su W.-W.; Hsieh T.-Y.; Lin C.-L.; Tsai W.-L.; Lee T.-H.; Chen G.-Y.; Wang S.-J.; Chang C.-C.; Mo L.-R.; Yang S.-S.; Wu W.-C.; Huang C.-S.; Hsiung C.-K.; Kao C.-N.; Tsai P.-C.; CHEN-HUA LIU; Lee M.-H.; Liu C.-J.; Dai C.-Y.; Kao J.-H.; Chuang W.-L.; Lin H.-C.; Yu M.-L. |
| 臺大學術典藏 |
2021-05-18T07:11:45Z |
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: A prospective study in men
|
Yu M.-W.;Yeh S.-H.;Chen P.-J.;Liaw Y.-F.;Lin C.-L.;Liu C.-J.;Wei-Liang Shih;Kao J.-H.;Chen D.-S.;Chen C.-J.; Yu M.-W.; Yeh S.-H.; Chen P.-J.; Liaw Y.-F.; Lin C.-L.; Liu C.-J.; WEI-LIANG SHIH; Kao J.-H.; Chen D.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-05-18T07:11:44Z |
Body-mass index and progression of hepatitis B: A population-based cohort study in men
|
Yu M.-W.;Wei-Liang Shih;Lin C.-L.;Liu C.-J.;Jian J.-W.;Tsai K.-S.;Chen C.-J.; Yu M.-W.; WEI-LIANG SHIH; Lin C.-L.; Liu C.-J.; Jian J.-W.; Tsai K.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-05-18T07:11:44Z |
Long-term tracking of hepatitis B viral load and the relationship with risk for hepatocellular carcinoma in men
|
Wu C.-F.;Yu M.-W.;Lin C.-L.;Liu C.-J.;Wei-Liang Shih;Tsai K.-S.;Chen C.-J.; Wu C.-F.; Yu M.-W.; Lin C.-L.; Liu C.-J.; WEI-LIANG SHIH; Tsai K.-S.; Chen C.-J. |
| 臺大學術典藏 |
2021-05-18T07:11:44Z |
Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area
|
Wei-Liang Shih;Yu M.-W.;Chen P.-J.;Yeh S.-H.;Lo M.-T.;Chang H.-C.;Liaw Y.-F.;Lin S.-M.;Liu C.-J.;Lee S.-D.;Lin C.-L.;Hsiao C.K.;Yang S.-Y.;Chen C.-J.; WEI-LIANG SHIH; Yu M.-W.; Chen P.-J.; Yeh S.-H.; Lo M.-T.; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Liu C.-J.; Lee S.-D.; Lin C.-L.; Hsiao C.K.; Yang S.-Y.; Chen C.-J. |
| 臺大學術典藏 |
2021-05-18T07:11:43Z |
Hepatitis B viraemia: Its heritability and association with common genetic variation in the interferon γ signalling pathway
|
Huang H.-H.;Wei-Liang Shih ;Li Y.-H.;Wu C.-F.;Chen P.-J.;Lin C.-L.;Liu C.-J.;Liaw Y.-F.;Lin S.-M.;Lee S.-D.;Yu M.-W.; Huang H.-H.; WEI-LIANG SHIH; Li Y.-H.; Wu C.-F.; Chen P.-J.; Lin C.-L.; Liu C.-J.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Yu M.-W. |
| 臺大學術典藏 |
2021-05-18T07:11:43Z |
Evidence for association with hepatocellular carcinoma at the PAPSS1 locus on chromosome 4q25 in a family-based study
|
WEI-LIANG SHIH; Yu M.-W.; Chen P.-J.; Wu T.-W.; Lin C.-L.; Liu C.-J.; Lin S.-M.; Tai D.-I.; Lee S.-D.; Liaw Y.-F. |
| 臺大學術典藏 |
2021-05-18T07:11:42Z |
Influences of tobacco and alcohol use on hepatocellular carcinoma survival
|
WEI-LIANG SHIH; Chang H.-C.; Liaw Y.-F.; Lin S.-M.; Lee S.-D.; Chen P.-J.; Liu C.-J.; Lin C.-L.; Yu M.-W. |
| 臺大學術典藏 |
2021-05-04T08:53:27Z |
Pregnancy Incidence in Female Nasopharyngeal Carcinoma Survivors of Reproductive Age
|
BO-CHING LEE; Yen R.-F.; Lin C.-L.; Liang J.-A.; Lin M.-C.; Kao C.-H. |
| 臺大學術典藏 |
2021-05-04T08:53:25Z |
Risk of acute kidney injury after transarterial chemoembolisation in hepatocellular carcinoma patients: A nationwide population-based cohort study
|
BO-CHING LEE; Liu K.-L.; Lin C.-L.; Kao C.-H. |
| 臺大學術典藏 |
2021-05-04T08:53:24Z |
Statin and the risk of ischemic stroke or transient ischemic attack in head and neck cancer patients with radiotherapy
|
BO-CHING LEE; Lin C.-L.; Tsai H.-H.; Kao C.-H. |
| 臺大學術典藏 |
2021-04-29T05:59:38Z |
Use and effectiveness of dapagliflozin in patients with type 2 diabetes mellitus: a multicenter retrospective study in Taiwan
|
Chen J.-F.;Peng Y.-S.;Chen C.-S.;Chin-Hsiao Tseng;Chen P.-C.;Lee T.I.;Lu Y.-C.;Yang Y.-S.;Lin C.-L.;Hung Y.-J.;Chen S.-T.;Lu C.-H.;Yang C.-Y.;Chen C.-C.;Lee C.-C.;Hsiao P.-J.;Jiang J.-Y.;Tu S.-T.; Chen J.-F.; Peng Y.-S.; Chen C.-S.; CHIN-HSIAO TSENG; Chen P.-C.; Lee T.I.; Lu Y.-C.; Yang Y.-S.; Lin C.-L.; Hung Y.-J.; Chen S.-T.; Lu C.-H.; Yang C.-Y.; Chen C.-C.; Lee C.-C.; Hsiao P.-J.; Jiang J.-Y.; Tu S.-T. |
| 臺大學術典藏 |
2021-04-26T01:47:25Z |
Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan
|
Shao Y.-Y.; Wang S.-Y.; Lin S.-M.; Chen K.-Y.; Tseng J.-H.; MING-CHIH HO; Lee R.-C.; Liang P.-C.; Liao L.-Y.; Huang K.-W.; Hu J.-T.; Liang J.-D.; Kee K.-M.; Lin C.-L.; Wang C.-K.; Lu S.-N.; Wang J.-H.; Lee W.-C.; Chen C.-H.; Liu C.-J.; Huang Y.-H.; Wang C.-C.; Wang T.-E.; Chuang P.-H.; Dai C.-Y.; Hsu C.; Chen S.-C.; Hsieh C.-H.; Diagnosis Group, Systemic Therapy Group |
| 臺大學術典藏 |
2021-04-21T23:30:01Z |
3D integration of vertical-stacking of MoS2and Si CMOS featuring embedded 2T1R configuration demonstrated on full wafers
|
Su, C. J.; Huang, M. K.; Lee, K. S.; Hu, V. P.H.; Ying-Fang Huang; Zheng, B. C.; Yao, C. H.; Lin, N. C.; Kao, K. H.; Hong, T. C.; Sung, P. J.; Wu, C. T.; Yu, T. Y.; Lin, K. L.; Tseng, Y. C.; Lin, C. L.; Lee, Y. J.; Chao, T. S.; Li, J. Y.; Wu, W. F.; Shieh, J. M.; Wang, Y. H.; Yeh, W. K. |
| 臺大學術典藏 |
2021-04-15T07:52:39Z |
Intracellular zinc release-activated ERK-dependent GSK-3Β-p53 and Noxa-Mcl-1 signaling are both involved in cardiac ischemic-reperfusion injury
|
Lin C.-L.; Tseng H.-C.; WEN-PIN CHEN; Su M.-J.; Fang K.-M.; Chen R.-F.; Wu M.-L. |
